Oriola Oyj
OMXH:OKDBV
Intrinsic Value
Oriola Corp. engages in the provision of pharmaceutical, and health and well-being products retail and wholesale. [ Read More ]
The intrinsic value of one OKDBV stock under the Base Case scenario is 3.876 EUR. Compared to the current market price of 0.932 EUR, Oriola Oyj is Undervalued by 76%.
Valuation Backtest
Oriola Oyj
Run backtest to discover the historical profit from buying and selling OKDBV stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Oriola Oyj
Current Assets | 550m |
Cash & Short-Term Investments | 109.8m |
Receivables | 260.1m |
Other Current Assets | 180.1m |
Non-Current Assets | 338.3m |
Long-Term Investments | 232.3m |
PP&E | 42.5m |
Intangibles | 50m |
Other Non-Current Assets | 13.5m |
Current Liabilities | 714.8m |
Accounts Payable | 578m |
Short-Term Debt | 24.5m |
Other Current Liabilities | 112.3m |
Non-Current Liabilities | 21.8m |
Long-Term Debt | 5.5m |
Other Non-Current Liabilities | 16.3m |
Earnings Waterfall
Oriola Oyj
Revenue
|
1.5B
EUR
|
Cost of Revenue
|
-1.4B
EUR
|
Gross Profit
|
157.4m
EUR
|
Operating Expenses
|
-162.4m
EUR
|
Operating Income
|
-5m
EUR
|
Other Expenses
|
-19.1m
EUR
|
Net Income
|
-24.1m
EUR
|
Free Cash Flow Analysis
Oriola Oyj
OKDBV Profitability Score
Profitability Due Diligence
Oriola Oyj's profitability score is 38/100. The higher the profitability score, the more profitable the company is.
Score
Oriola Oyj's profitability score is 38/100. The higher the profitability score, the more profitable the company is.
OKDBV Solvency Score
Solvency Due Diligence
Oriola Oyj's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Score
Oriola Oyj's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
OKDBV Price Targets Summary
Oriola Oyj
According to Wall Street analysts, the average 1-year price target for OKDBV is 1.088 EUR with a low forecast of 1.01 EUR and a high forecast of 1.155 EUR.
Shareholder Return
OKDBV Price
Oriola Oyj
Average Annual Return | -0.05% |
Standard Deviation of Annual Returns | 8.35% |
Max Drawdown | -59% |
Market Capitalization | 169.1m EUR |
Shares Outstanding | 181 423 000 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Oriola Corp. engages in the provision of pharmaceutical, and health and well-being products retail and wholesale. The company is headquartered in Espoo, Etela-Suomen and currently employs 2,645 full-time employees. The company went IPO on 2006-07-03. The firm is engaged in the retail and wholesale of pharmaceuticals, acting as a channel between pharmaceutical manufacturers and consumers, primarily in Finland and Sweden. The firm's reporting segments are Consumer, Services, and Healthcare. Through its own pharmacies, the Company provides consumers with not only medicines and pharmaceutical advice but also a selection of healthcare consumer products and customer service. The firm is active through a number of subsidiaries located throughout Europe, including PharmaService OY, Oriola AB, Oriola Oyj, Farenta Oy, Kronans Droghandel Apotek AB and Svensk dos AB.
Contact
IPO
Employees
Officers
The intrinsic value of one OKDBV stock under the Base Case scenario is 3.876 EUR.
Compared to the current market price of 0.932 EUR, Oriola Oyj is Undervalued by 76%.